W. Va. Code R. § 24-2-2

Current through Register Vol. XLI, No. 25, June 21, 2024

Section 24-2-2 - [Effective until 7/1/2024] Definitions

2.1. For purposes of this rule, the following words and terms mean the following:

2.1.a. "Active practice notification" means a practice notification which is currently in effect.

2.1.b. "Authorization to practice" means written notification from the Board that a physician assistant may commence practice in collaboration with physicians pursuant to an active practice notification.

2.1.c. "Board" means the West Virginia Board of Osteopathic Medicine.

2.1.d. "Collaborating Physician" means a doctor of osteopathic medicine, medicine, or podiatry, who is authorized to practice clinical medicine or podiatric medicine in West Virginia by the appropriate board in this state, without restriction or limitation, who collaborates with physician assistants.

2.1.e. "Collaboration" means overseeing the activities of the medical services rendered by a physician assistant. Constant physical presence of the collaborating physician is not required as long as the collaborating physician and physician assistant are, or can be, easily in contact with one another by telecommunication. Collaboration does not require the personal presence of the collaborating physician at the place or places where services are rendered.

2.1.f. "Controlled substances" means drugs that are classified by federal or state law in Schedules I, II, III, IV or V, as defined in W. Va. Code §§ 60A-2-204 through 212.

2.1.g. "Core duties" means medical acts that are included in the standard curricula of accredited physician assistant education programs.

2.1.h. "Drug diversion training and best practice prescribing of controlled substances training" means training which includes all of the following:

2.1.h.1. Drug diversion, including West Virginia statistics on prescription drug abuse and resulting deaths.

2.1.h.2. Epidemiology of chronic pain and misuse of opioids.

2.1.h.3. Indication for opioids in chronic pain treatment including general characteristics, toxicities and drug interactions.

2.1.h.4. Examination of patient evaluation and risk assessment and tools to assess risk and monitor benefits.

2.1.h.5. Initiation and ongoing management of chronic pain patient treated with opioid based therapies, including treatment objectives; monitoring and periodic review; referrals and consultations; informed consent; prescription of controlled substance agreements, urine screens and pill counts; patient education on safe use, storage and disposal of opioids; discontinuation of opioids for pain due to lack of benefits or increased risks; documentation and medical records.

2.1.h.6. Case study of a patient with chronic pain.

2.1.h.7. Identification of diversion and drug seeking tactics and behaviors.

2.1.h.8. Best practice methods for working with patients suspected of drug seeking behavior and diversion.

2.1.h.9. Compliance with controlled substances laws and rules.

2.1.h.10. Training on prescribing and administration of an opioid antagonist.

2.1.h.11. Registration with and use of the West Virginia Controlled Substances Monitoring Program established in W. Va. Code § 60A-9-1et seq.

2.1.h.12. Information related to substance use disorder treatment referral, including but not limited to programs and initiatives developed through the Governor's Council on Substance Abuse Prevention and Treatment, the Governor's Committee on Crime, Delinquency, and Correction, and/or W. Va. Code § 15-9-7.

2.1.h.13. Maintenance of a record of attendance of each individual who successfully completes the drug diversion training and best practice prescribing of controlled substances training.

2.1.h.14. Training on the impacts of stigma on treatment effectiveness including the concept of addiction as a chronic disease.

2.1.h.15. Introduction to Medication for Opioid Use Disorder (MOUD) and training on the effectiveness of MOUD treatment including the use of full opioid agonist, partial opioid agonist, and opioid antagonists.

2.1.i. "Endorsement" means a summer camp or volunteer endorsement to practice as a physician assistant under W. Va. Code § 30-3E-1.

2.1.j. "Health Care Facility" means any licensed hospital, nursing home, extended care facility, state health or mental institution, clinic or physician's office.

2.1.k. "Hospital" means a facility licensed pursuant to W. Va. Code § 16-5B-1et seq.

2.1.l. "License" means a license issued by the Board to a physician assistant applicant pursuant to the provisions of W. Va. Code § 30-3E-1et seq. and the provisions of this legislative rule.

2.1.m. "Licensee" means a physician assistant licensed pursuant to the provisions of W. Va. Code § 30-3E-1et seq. and the provisions of this legislative rule.

2.1.n. "Licensure" means the process of application to the Board and the Board's consideration and approval of individuals to practice as a physician assistant in collaboration with physicians.

2.1.o. "Narcotic drug" and "opioid" mean controlled substance medications which are natural and semi-synthetic derivatives of the opium poppy, as well as similar synthetic compounds that have analgesic or pain-relieving properties because of their effects in the central nervous system. Narcotic drugs and opioids include, but are not limited to, codeine, morphine, hydromorphone, hydrocodone, oxycodone, methadone, and fentanyl.

2.1.p. "NCCPA" means The National Commission on the Certification of Physician Assistants.

2.1.q. "Medical Board" means the West Virginia Board of Medicine.

2.1.r. "Physician" means a doctor of allopathic or osteopathic medicine who is fully licensed by this Board or the Board of Medicine to practice medicine or surgery in this state.

2.1.s. "Physician Assistant" means a person who meets the qualifications set forth in the Physician Assistants Practice Act, W. Va. Code § 30-3E-1et seq., and is licensed to practice medicine with a collaborating osteopathic physician. Physician assistant also means an individual who holds a physician assistant license in another state and an interstate telehealth registration issued by this Board.

2.1.t. "Practice notification" means a written notice to the Board that a physician assistant will practice in collaboration with one or more physicians in the state of West Virginia.

2.1.u. "Practice setting" means the type of practice environment, and includes hospitals, ambulatory surgical facilities, clinics, private medical offices, and long term care facilities.

2.1.v. "Prescription drug" means a drug that may be dispensed under federal or state law only pursuant to the prescription of an authorized prescriber.

2.1.w. "Prescriptive authority" means the authority of a physician assistant to prescribe, order, administer or dispense prescription drugs.

2.1.x. "Registrant" means a physician assistant issued an interstate telehealth registration by the Board pursuant to W. Va. Code § 30-1-26.

2.1.y. "Registration" means an authorization to practice in collaboration with physicians issued by the Board pursuant to W. Va. Code § 30-1-26 for the limited purpose of providing interstate telehealth services.

2.1.z. "Reporting period" means the two-year period preceding the renewal deadline for a license issued by the Board.

2.1.aa. "Website" or "Board's website" means the set of related web pages operated by or on behalf of the West Virginia Board of Osteopathic Medicine located at the domain name www.wvbdosteo.org, or at any successor domain name published by the Board.

W. Va. Code R. § 24-2-2